PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 14, 2026Food Chemistry International0 citationsOpen Access

Nutritional Potential, Phytochemical Content, In Vivo Antioxidant, and Antanemic Potential of Musa paradisiaca Flower

View Full Paper
JNJosée Rebeca NomboJEJethro Roland Misse Ngangue EkwalaSTSomon Régine Tuem

Key Points

  • To assess the nutritional capacity and impact of Musa paradisiaca flower extract on anemic rats.
  • Analyzed phytonutrients and proximate composition using AOAC standard procedures.
  • Administered flower extract (AEMPF) to anemic rats at varying doses.
  • Evaluated hematological and biochemical indicators after a 2-week treatment.
  • Findings showed significant increases in hemoglobin and red blood cells in groups receiving AEMPF.
  • Polyphenols, carotenoids, and vitamin C were present in the flower extract.
  • 400 mg/kg dosage was the most effective in treating hemolytic anemia.

Abstract

ABSTRACT This work was done in view to assess the nutritional capacity and impact of Musa paradisiaca flower extract on anemic rats. AOAC standard procedures were used to analyze the phytonutrients, minerals, and proximate composition. Six groups of 36 rats were allocated. Extract of flower (AEMPF) was administered to anemic rats in Groups 4, 5, and 6 at doses of 100, 200, and 400 mg/kg, respectively. Group 1 consisted of untreated rats, Group 2 of untreated anemic rats, and Group 3 of anemic rats treated with the usual medication ferrous sulfate (Ranferon) at a dose of 5 mg/kg. Over the course of two days, an intraperitoneal injection of a phenylhydrazine solution (60 mg/kg) was used to induce anemia. Hematological, biochemical, and oxidative stress indicators were examined following a 2‐week course of treatment. According to the findings, these flowers include potassium (521.25 mg/100 g), fiber (52.06%), carotenoids (56.82 mg/100 g), polyphenols (129.29 mg/100 g), and vitamin C (5.63 mg/100 g). Hematocrit, hemoglobin, and red blood cells were all considerably ( p < 0.05) higher in the AEMPF‐treated anemic groups than in the untreated anemic group. When AEMPF was administered to Groups 4, 5, and 6, the lipid profile, lactate dehydrogenase activity, direct bilirubin, and creatinine all showed substantial ( p < 0.05) improvements in comparison to Groups 2 and 3. Superoxide dismutase, catalase, and reduced glutathione levels were significantly ( p < 0.05) higher in Groups 4, 5, and 6 than in Group 3. The most effective dosage was 400 mg/kg, and hemolytic anemia could be treated with AEMPF.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nombo et al. (2026) studied this question.

synapsesocial.com/papers/6966f33213bf7a6f02c010bchttps://doi.org/10.1002/fci2.70053
Ask AI
Helpful
Bookmark
Share
View Full Paper